Clinical and Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, United States.
Clinical and Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, United States.
Diabetes Res Clin Pract. 2020 Sep;167:108357. doi: 10.1016/j.diabres.2020.108357. Epub 2020 Jul 31.
This study estimates incidence of diabetes (DM) and pre-DM relative to DM risk factors among relatively healthy Alaska Native and American Indian (henceforth AN) adults living in urban south central Alaska.
Baseline (2004-2006) and follow-up (2014-2017) surveys, blood samples, and medical chart review data were collected from AN adults living in south central Alaska. We analyzed associations between prevalent risk factors and incident DM and pre-DM using Cox proportional hazards and used multivariable models to identify independent predictors for both DM and pre-DM.
Among 379 participants with follow-up data, overall DM incidence was 16.5/1,000 PY; overall pre-DM incidence was 77.6/1,000 PY, with marked differences between men and women. Prevalent cardiometabolic risk factors also varied with greater amounts of overweight in men and greater amounts of obesity in women. Controlling for age and sex, obesity, abdominal adiposity, pre-DM, and metabolic syndrome independently increased DM risk.
Health care providers of AN populations must seize the opportunity to screen, refer, and treat individuals with pre-DM and other modifiable DM risk factors prior to DM diagnosis if we are to alter the epidemiologic course of disease progression in this urban AN population.
本研究旨在评估生活在阿拉斯加中南部城市的相对健康的阿拉斯加原住民和美洲印第安人(以下简称 AN)成年人中,与糖尿病(DM)相关的糖尿病(DM)和糖尿病前期(DM)的发病率及其与 DM 危险因素的关系。
从生活在阿拉斯加中南部的 AN 成年人中收集了基线(2004-2006 年)和随访(2014-2017 年)调查、血液样本和病历回顾数据。我们使用 Cox 比例风险分析评估了现患危险因素与新发 DM 和 pre-DM 之间的关系,并使用多变量模型确定了 DM 和 pre-DM 的独立预测因素。
在 379 名有随访数据的参与者中,总的 DM 发病率为 16.5/1000PY;总的 pre-DM 发病率为 77.6/1000PY,男女之间存在显著差异。心血管代谢风险因素也存在差异,男性超重较多,女性肥胖较多。在控制年龄和性别后,肥胖、腹部肥胖、pre-DM 和代谢综合征独立增加了 DM 风险。
如果我们要改变这一城市 AN 人群中疾病进展的流行病学进程,那么 AN 人群的医疗保健提供者必须抓住机会,在 DM 诊断前对 pre-DM 和其他可改变的 DM 危险因素进行筛查、转介和治疗。